首页> 外文期刊>Cell transplantation >MR tracking of magnetically labeled mesenchymal stem cells in rat kidneys with acute renal failure.
【24h】

MR tracking of magnetically labeled mesenchymal stem cells in rat kidneys with acute renal failure.

机译:急性肾衰竭大鼠肾脏中磁性标记的间充质干细胞的MR追踪。

获取原文
获取原文并翻译 | 示例
           

摘要

Stem cell transplantation is emerging as a potential treatment option for acute renal failure (ARF) because of its capability to regenerate tissues and organs. To better understand the mechanism of cell therapy, in vivo tracking cellular dynamics of the transplanted stem cells is needed. In the present study, in vivo monitored magnetically labeled mesenchymal stem cells (MSCs) were transplanted intravascularly into an ARF rat model using a conventional magnetic resonance imaging (MRI) system. Rat bone marrow MSCs were labeled with home synthesized Fe2O3-PLL, and labeled (n = 6) or unlabeled MSCs (n = 6) were injected into the renal arteries of the rats with ARF induced by the intramuscular injection of glycerol. Using the same technique, labeled MSCs were also injected into the rats assigned to a control group (n = 8). MR images of kidneys were obtained before injection of MSCs as well as immediately, 1, 3, 5, and 8 days afterwards. MR findings were analyzed and compared with histopathological and immunohistochemical results. These results showed that the rat MSCs were successfully labeled with the home synthesized Fe2O3-PLL. In both renal failure and intact rat models, the labeled MSCs demonstrated a loss of signal intensity in the renal cortex on T2*-weighted MR images, which was visible up to 8 days after transplantation. Histological analyses showed that most of the labeled MSCs that tested positive for Prussian blue staining were in glomerular capillaries, corresponding to the areas where a loss in signal intensity was observed in the MRI. A similar signal intensity decrease was not detected in the rats with unlabeled cells. These data demonstrate that the magnetically labeled MSCs in the rat model of ARF were successfully evaluated in vivo by a 1.5 T MRI system, showing that the mechanisms of stem cell therapy have great potential for future ARF treatment recipients.
机译:干细胞移植由于其具有再生组织和器官的能力,正在成为急性肾衰竭(ARF)的潜在治疗选择。为了更好地了解细胞疗法的机制,需要体内跟踪移植的干细胞的细胞动力学。在本研究中,使用常规磁共振成像(MRI)系统将体内监测的磁性标记的间充质干细胞(MSC)血管内移植到ARF大鼠模型中。用自制的Fe2O3-PLL标记大鼠骨髓MSC,并通过肌肉注射甘油将ARF标记的(n = 6)或未标记的MSC(n = 6)注入大鼠肾动脉。使用相同的技术,还将标记的MSC注射入分配为对照组的大鼠(n = 8)。肾脏的MR图像是在注射MSC之前以及之后,1、3、5和8天后获得的。 MR结果进行了分析,并与组织病理学和免疫组织化学结果进行了比较。这些结果表明,用自制的Fe2O3-PLL成功标记了大鼠MSC。在肾衰竭和完整大鼠模型中,标记的MSC在T2 *加权MR图像上均显示出肾皮质中信号强度的丧失,这种现象在移植后长达8天可见。组织学分析表明,对普鲁士蓝染色测试呈阳性的大多数标记MSC位于肾小球毛细血管中,这与在MRI中观察到信号强度降低的区域相对应。在未标记细胞的大鼠中未检测到类似的信号强度下降。这些数据表明,通过1.5 T MRI系统在体内成功评估了ARF大鼠模型中的磁性标记MSC,表明干细胞治疗的机制对于未来的ARF治疗接受者具有巨大的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号